Home›Search›Metabolic Brain Disease

Metabolic Brain Disease

Springer · United States · Est. 1986

ISSN1573-7365

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (2 more)+12

Total90

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

146

days submission → published

measured · last 20 articles · accept 119d

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.995

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.856

Total Worksi

3,477

Total Citationsi

82,486

2yr Mean Citednessi

3.11

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Metabolic Brain Disease is a forum for publishing high-quality basic and clinical papers on a broad range of brain disorders in human and animal studies. Topics include stroke, traumatic brain injury, myelin disorders, epilepsy, multiple sclerosis, toxic encephalopathies, genetic diseases affecting the brain, alcohol and brain metabolism, neuroendocrinopathies, viral and nonviral encephalitides, nutritional disorders affecting the brain, diseases affecting neurotransmitters, Alzheimer's disease, Parkinson’s disease, amyotrophic lateral and more. The journal serves neuroscientists, psychiatrists, neurologists, pathologists, and others involved in research and treatment of brain disorders. We will consider research papers, short communications, review articles and editorials.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1986

Annual Volume~ 204 articles / year

StatusActive (last: 2026)

Total Publications3,477

Publisher OrgSpringer Science+Business Media

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Springer

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1573-7365

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

162

4.2k

2019

121

2020

225

4.7k

2021

272

3.9k

2022

184

1.9k

2023

162

2024

267

967

2025

144

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

BiochemistryQ2

Cellular and Molecular NeuroscienceQ2

Neurology (clinical)Q2

Subject Classification

Web of Science Categories

Endocrinology & MetabolismNeurosciences

Scopus Categories

Neurology (clinical)BiochemistryCellular and Molecular Neuroscience

Research Topics (OpenAlex)

Neuroscience and Neuropharmacology ResearchLiver Disease and TransplantationMetabolism and Genetic DisordersNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersAlzheimer's disease research and treatmentsMitochondrial Function and PathologyLiver Disease Diagnosis and TreatmentDiet and metabolism studiesStress Responses and Cortisol

Frequently asked questions about Metabolic Brain Disease

Is Metabolic Brain Disease a predatory journal?

PubScope has no integrity flags on record for Metabolic Brain Disease: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Metabolic Brain Disease?

Metabolic Brain Disease is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.11.

Is Metabolic Brain Disease indexed in Scopus and Web of Science?

Metabolic Brain Disease is indexed in Web of Science, Scopus.